Hyperfine, Inc. (NASDAQ:HYPR - Free Report) - Equities researchers at B. Riley issued their Q1 2025 earnings per share (EPS) estimates for shares of Hyperfine in a report released on Wednesday, March 19th. B. Riley analyst Y. Zhi anticipates that the company will post earnings of ($0.12) per share for the quarter. B. Riley currently has a "Buy" rating and a $1.20 price target on the stock. The consensus estimate for Hyperfine's current full-year earnings is ($0.57) per share. B. Riley also issued estimates for Hyperfine's Q2 2025 earnings at ($0.12) EPS, Q3 2025 earnings at ($0.12) EPS, Q4 2025 earnings at ($0.13) EPS and FY2025 earnings at ($0.49) EPS.
A number of other equities analysts have also weighed in on HYPR. Wells Fargo & Company boosted their price objective on shares of Hyperfine from $1.10 to $1.29 and gave the company an "equal weight" rating in a research report on Tuesday, March 18th. Lake Street Capital started coverage on Hyperfine in a report on Monday. They issued a "buy" rating and a $1.50 price target for the company.
Read Our Latest Research Report on Hyperfine
Hyperfine Price Performance
NASDAQ:HYPR traded down $0.02 on Monday, reaching $0.78. The stock had a trading volume of 347,241 shares, compared to its average volume of 363,776. Hyperfine has a 12-month low of $0.76 and a 12-month high of $1.90. The company has a market cap of $56.72 million, a price-to-earnings ratio of -1.36 and a beta of 0.94. The firm's fifty day moving average is $1.06 and its two-hundred day moving average is $1.00.
Hyperfine (NASDAQ:HYPR - Get Free Report) last issued its quarterly earnings data on Monday, March 17th. The company reported ($0.14) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.16) by $0.02. The business had revenue of $2.32 million for the quarter, compared to the consensus estimate of $2.30 million. Hyperfine had a negative return on equity of 57.54% and a negative net margin of 309.42%. During the same period in the prior year, the business earned ($0.15) earnings per share.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently modified their holdings of the stock. Geode Capital Management LLC grew its holdings in Hyperfine by 18.7% in the third quarter. Geode Capital Management LLC now owns 624,520 shares of the company's stock valued at $675,000 after purchasing an additional 98,335 shares during the period. Graypoint LLC acquired a new position in shares of Hyperfine in the 4th quarter valued at $44,000. Virtu Financial LLC acquired a new position in shares of Hyperfine in the 4th quarter valued at $25,000. Renaissance Technologies LLC grew its stake in shares of Hyperfine by 32.9% during the 4th quarter. Renaissance Technologies LLC now owns 212,300 shares of the company's stock valued at $187,000 after buying an additional 52,500 shares during the period. Finally, Wealth Enhancement Advisory Services LLC increased its holdings in shares of Hyperfine by 64.3% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 82,008 shares of the company's stock worth $72,000 after buying an additional 32,093 shares during the last quarter. Institutional investors and hedge funds own 15.03% of the company's stock.
About Hyperfine
(
Get Free Report)
Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.
Recommended Stories
Before you consider Hyperfine, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hyperfine wasn't on the list.
While Hyperfine currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.